QCG
STJ

Quadrant Capital Group’s St Jude Medical STJ Stock Holding History

Quadrant Capital Group’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,107
Closed -$82K – 2217
2016
Q4 		$82K Sell
1,107
-3
-0.3% -$238 0.04% 310
2016
Q3 		$83K Sell
1,110
-10
-0.9% -$807 0.05% 289
2016
Q2 		$82K Buy
1,120
+156
+16% +$11.1K 0.06% 267
2016
Q1 		$50K Sell
964
-57
-6% -$3.11K 0.03% 390
2015
Q4 		$59K Sell
1,021
-81
-7% -$5.11K 0.04% 351
2015
Q3 		$68K Sell
1,102
-54
-5% -$3.85K 0.05% 326
2015
Q2 		$83K Buy
+1,156
New +$83.5K 0.05% 297

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Quadrant Capital Group's STJ Position: Q1 2017 in Review

Quadrant Capital Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 1,107 shares — an estimated $82K sold.

Quadrant Capital Group first reported a position in STJ in Q2 2015 and held it in 7 quarters. The position peaked at $83K in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Quadrant Capital Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Quadrant Capital Group sold 1,107 St Jude Medical shares in Q1 2017, an estimated $82K.
  • Quadrant Capital Group first reported a position in St Jude Medical in Q2 2015 and held it in 7 quarters.
  • Quadrant Capital Group's St Jude Medical position peaked at $83K in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Quadrant Capital Group's 13F filing for Q1 2017, filed 10 Apr 2017.